Loss of fingerprints secondary to palmoplantar erythrodysesthesia in a patient on capecitabine chemotherapy

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6023 (Published 25 November 2015) Cite this as: BMJ 2015;351:h6023
  1. Sara Lightowlers, speciality registrar in clinical oncology,
  2. Rubin Soomal, consultant clinical oncologist
  1. 1Department of Oncology, Ipswich Hospital, Ipswich IP4 5PD, UK
  1. lightowlers{at}doctors.org.uk

A 47 year old man on oxaliplatin and capecitabine chemotherapy developed dryness and erythema of the palms of his hands. He noticed he was unable …

View Full Text

Log in

Log in through your institution


* For online subscription